File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans

TitleCAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans
Authors
Tang, SCheng, CCTse, KCLi, FKChoy, BYChan, TMLai, KN
KeywordsAlcaligenes xylosoxidans
Continuous ambulatory peritoneal dialysis
Peritonitis
Treatment, infectious peritonitis
Issue Date2001
PublisherS Karger AG. The Journal's web site is located at http://www.karger.com/AJN
Citation
American Journal Of Nephrology, 2001, v. 21 n. 6, p. 502-506 How to Cite?
DOI: http://dx.doi.org/10.1159/000046657
AbstractAlcaligenes xylosoxidans is an uncommon cause of peritonitis in patients on maintenance continuous ambulatory peritoneal dialysis (CAPD). Peritonitis caused by A. xylosoxidans usually carries a poor prognosis because of the pathogen's virulence and its universal resistance to most antimicrobial agents. Even after early Tenckhoff catheter removal, the transport property of the peritoneum is often irreversibly damaged, leading to permanent technique failure. We report 2 patients with CAPD-associated peritonitis due to A. xylosoxidans sp. xylosoxidans who were successfully cured with a combination of piperacillin and tazobactam. One of them subsequently returned uneventfully to CAPD. Copyright © 2001 S. Karger AG, Basel.
Persistent Identifierhttp://hdl.handle.net/10722/162548
ISSN
0250-8095
2021 Impact Factor: 4.605
2020 SCImago Journal Rankings: 1.394
ISI Accession Number ID
WOS:000173207600013
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorTang, Sen_HK
dc.contributor.authorCheng, CCen_HK
dc.contributor.authorTse, KCen_HK
dc.contributor.authorLi, FKen_HK
dc.contributor.authorChoy, BYen_HK
dc.contributor.authorChan, TMen_HK
dc.contributor.authorLai, KNen_HK
dc.date.accessioned2012-09-05T05:20:58Z-
dc.date.available2012-09-05T05:20:58Z-
dc.date.issued2001en_HK
dc.identifier.citationAmerican Journal Of Nephrology, 2001, v. 21 n. 6, p. 502-506en_HK
dc.identifier.issn0250-8095en_HK
dc.identifier.urihttp://hdl.handle.net/10722/162548-
dc.description.abstractAlcaligenes xylosoxidans is an uncommon cause of peritonitis in patients on maintenance continuous ambulatory peritoneal dialysis (CAPD). Peritonitis caused by A. xylosoxidans usually carries a poor prognosis because of the pathogen's virulence and its universal resistance to most antimicrobial agents. Even after early Tenckhoff catheter removal, the transport property of the peritoneum is often irreversibly damaged, leading to permanent technique failure. We report 2 patients with CAPD-associated peritonitis due to A. xylosoxidans sp. xylosoxidans who were successfully cured with a combination of piperacillin and tazobactam. One of them subsequently returned uneventfully to CAPD. Copyright © 2001 S. Karger AG, Basel.en_HK
dc.languageengen_US
dc.publisherS Karger AG. The Journal's web site is located at http://www.karger.com/AJNen_HK
dc.relation.ispartofAmerican Journal of Nephrologyen_HK
dc.subjectAlcaligenes xylosoxidansen_HK
dc.subjectContinuous ambulatory peritoneal dialysisen_HK
dc.subjectPeritonitisen_HK
dc.subjectTreatment, infectious peritonitisen_HK
dc.subject.meshAdulten_US
dc.subject.meshAlcaligenesen_US
dc.subject.meshEnzyme Inhibitors - Therapeutic Useen_US
dc.subject.meshFemaleen_US
dc.subject.meshGram-Negative Bacterial Infections - Drug Therapy - Etiologyen_US
dc.subject.meshHumansen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPenicillanic Acid - Analogs & Derivatives - Therapeutic Useen_US
dc.subject.meshPenicillins - Therapeutic Useen_US
dc.subject.meshPeritoneal Dialysis, Continuous Ambulatory - Adverse Effectsen_US
dc.subject.meshPeritonitis - Drug Therapy - Microbiologyen_US
dc.subject.meshPiperacillin - Therapeutic Useen_US
dc.titleCAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidansen_HK
dc.typeArticleen_HK
dc.identifier.emailTang, S: scwtang@hku.hken_HK
dc.identifier.emailChan, TM: dtmchan@hku.hken_HK
dc.identifier.emailLai, KN: knlai@hku.hken_HK
dc.identifier.authorityTang, S=rp00480en_HK
dc.identifier.authorityChan, TM=rp00394en_HK
dc.identifier.authorityLai, KN=rp00324en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1159/000046657en_HK
dc.identifier.pmid11799270-
dc.identifier.scopuseid_2-s2.0-0035702518en_HK
dc.identifier.hkuros67223-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0035702518&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume21en_HK
dc.identifier.issue6en_HK
dc.identifier.spage502en_HK
dc.identifier.epage506en_HK
dc.identifier.isiWOS:000173207600013-
dc.publisher.placeSwitzerlanden_HK
dc.identifier.scopusauthoridTang, S=7403437082en_HK
dc.identifier.scopusauthoridCheng, CC=7404796652en_HK
dc.identifier.scopusauthoridTse, KC=7102609864en_HK
dc.identifier.scopusauthoridLi, FK=8219093900en_HK
dc.identifier.scopusauthoridChoy, BY=7003465499en_HK
dc.identifier.scopusauthoridChan, TM=7402687700en_HK
dc.identifier.scopusauthoridLai, KN=7402135706en_HK
dc.identifier.issnl0250-8095-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats